introduct
retrospect
studi
investig
implic
chang
blood
paramet
cellular
immun
function
patient
infect
diseas
method
record
review
patient
februari
primari
outcom
inhospit
mortal
day
result
fourteen
patient
die
baselin
leukocyt
count
neutrophil
count
hemoglobin
significantli
higher
nonsurvivor
compar
survivor
revers
true
lymphocyt
count
platelet
pao
fio
count
count
percentag
neutrophil
count
l
death
group
significantli
higher
surviv
group
multivari
logist
regress
show
neutrophil
count
independ
associ
mortal
howev
signific
differ
igg
igm
iga
percentag
ige
iuml
death
group
surviv
group
area
receiv
oper
characterist
curv
follow
baselin
could
significantli
predict
mortal
leukocyt
neutrophil
lymphocyt
count
patient
lymphocyt
count
mark
decreas
suggest
poor
outcom
high
neutrophil
count
independ
associ
mortal
admiss
leukocyt
neutrophil
lymphocyt
count
receiv
ad
attent
first
case
unknown
pneumonia
trace
wuhan
south
china
seafood
market
decemb
confirm
acut
respiratori
infecti
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
formerli
known
diseas
subsequ
name
infect
diseas
feb
present
epidem
wrought
great
damag
china
asia
europ
north
america
global
countri
threat
highli
contagi
caus
seriou
lung
injuri
result
death
medic
research
concern
new
viru
rel
limit
pathophysiolog
mechan
underli
caus
diseas
still
studi
pulmonari
infect
caus
viru
often
accompani
chang
hematolog
immun
test
paramet
neutrophil
lymphocyt
lymphocyt
subset
count
may
help
clinician
assess
condit
patient
viral
pneumonia
patient
sever
acut
respiratori
syndrom
sar
initi
neutrophil
count
odd
ratio
initi
creactiv
protein
crp
concentr
mgl
associ
fatal
leong
et
al
found
neutropenia
associ
poor
prognosi
patient
sar
li
et
al
report
peripher
lymphocyt
absolut
count
significantli
lower
patient
tang
et
al
also
show
lymphocyt
significantli
decreas
acut
phase
sar
especi
patient
die
wang
et
al
show
patient
mark
lymphopenia
nonsurvivor
develop
sever
lymphopenia
time
hospit
anoth
studi
also
indic
patient
death
group
significantli
lower
lymphocyt
count
admiss
recov
group
howev
explor
chang
lymphocyt
subset
recent
sever
studi
show
compar
nonsever
case
sever
case
lower
lymphocyt
count
higher
leukocyt
count
wang
et
al
found
cell
cell
b
cell
natur
killer
nk
cell
decreas
patient
sever
case
lower
level
mild
case
studi
also
mention
cell
decreas
patient
howev
whether
chang
humor
immun
function
studi
yet
differ
lymphocyt
subset
surviv
death
patient
rare
studi
may
lead
hyperact
inflammatori
respons
suppress
immun
respons
chang
leukocyt
subset
immun
function
infect
may
suggest
immun
statu
well
studi
object
present
case
seri
compar
clinic
characterist
blood
analys
immun
function
featur
survivor
nonsurvivor
predict
valu
neutrophil
lymphocyt
lymphocyt
subset
admiss
mortal
also
studi
ethic
committe
children
hospit
chongq
medic
univers
institut
review
board
children
hospit
chongq
medic
univers
approv
retrospect
cohort
studi
requir
written
inform
consent
waiv
retrospect
design
studi
popul
compris
patient
pneumonia
admit
ward
third
batch
chongq
medic
aid
team
wuhan
citi
hubei
provinc
china
februari
februari
data
analyz
anonym
patient
studi
confirm
infect
revers
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
assay
nose
throat
swab
sampl
least
one
ground
glass
chang
lung
indic
chest
comput
tomographi
ct
scan
blood
routin
immun
function
test
complet
within
hour
admiss
patient
follow
exclud
studi
death
due
natur
caus
rather
viral
infect
immunodefici
longterm
use
glucocorticoid
immunosuppress
collect
inform
includ
age
gender
concomit
diseas
symptom
hemoglobin
platelet
leukocyt
neutrophil
lymphocyt
count
crp
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
igg
igm
iga
ige
chest
ct
alanin
aminotransferas
creatinin
arteri
blood
ga
result
rtpcr
assay
rna
patient
outcom
surviv
death
follow
march
primari
outcom
inhospit
mortal
day
data
analyz
use
spss
spss
chicago
il
usa
continu
variabl
shown
median
interquartil
rang
iqr
categor
data
percentag
comparison
two
median
perform
use
mannwhitney
u
test
comparison
percentag
chisquar
test
multivari
analysi
perform
determin
whether
admiss
neutrophil
count
risk
factor
mortal
adjust
admiss
lymphocyt
count
pao
fio
crp
mgl
receiv
oper
characterist
roc
curv
use
determin
blood
paramet
admiss
predictor
mortal
pvalu
consid
statist
signific
analys
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
overal
person
treat
studi
period
men
met
inclus
criteria
studi
tabl
remain
other
exclud
due
absenc
specif
blood
test
within
hour
admiss
neg
result
nasopharyng
swab
sampl
death
due
advanc
age
rather
viru
infect
age
studi
popul
year
rang
interv
symptom
onset
admiss
signific
differ
age
surviv
death
group
cf
tabl
death
group
percentag
men
rate
accompani
diseas
higher
compar
surviv
group
respect
differ
signific
incid
dyspnea
death
group
higher
surviv
group
surviv
death
group
also
compar
regard
interv
onset
admiss
cf
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
follow
blood
paramet
death
group
significantli
higher
surviv
group
tabl
total
leukocyt
count
p
percentag
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
neutrophil
p
neutrophil
count
p
hemoglobin
p
upon
admiss
percentag
death
group
crp
mgl
significantli
higher
surviv
group
cf
addit
patient
death
group
admiss
neutrophil
count
l
true
surviv
group
death
group
percentag
lymphocyt
lymphocyt
count
platelet
count
pao
fio
significantli
lower
surviv
group
p
respect
patient
death
group
lymphocyt
count
baselin
l
howev
true
surviv
group
patient
baselin
median
count
lower
lower
limit
normal
rang
tabl
count
patient
lower
lower
limit
normal
rang
respect
incid
rate
higher
nonsurvivor
survivor
tabl
median
count
count
death
group
significantli
lower
surviv
group
p
respect
median
count
count
count
ratio
death
group
lower
surviv
group
differ
statist
signific
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
patient
overal
test
humor
immun
function
howev
signific
differ
igg
igm
iga
percentag
ige
iuml
death
group
surviv
group
tabl
area
roc
curv
auc
predictor
mortal
determin
analys
blood
paramet
baselin
calcul
compar
tabl
auc
show
follow
could
predict
death
due
leukocyt
count
neutrophil
percentag
neutrophil
count
lymphocyt
percentag
lymphocyt
count
count
count
pao
fio
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
surviv
group
n
treatment
symptom
cough
short
breath
dyspnea
reliev
vari
degre
chest
ct
gradual
improv
four
patient
well
enough
discharg
within
week
admiss
remain
hospit
survivor
underw
blood
test
week
treatment
lymphocyt
count
neutrophil
count
return
normal
rang
patient
howev
surviv
patient
week
treatment
lymphocyt
count
still
lower
limit
normal
l
addit
surviv
patient
week
treatment
neutrophil
count
higher
limit
normal
l
patient
test
cellular
immun
surviv
group
week
hospit
count
lymphocyt
subset
return
normal
rang
patient
tabl
howev
patient
count
remain
lower
lower
limit
normal
refer
valu
patient
count
still
lower
lower
limit
normal
refer
valu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
sinc
decemb
preval
wuhan
china
highli
contagi
humantohuman
transmiss
sever
case
lead
death
patient
sever
diseas
may
respiratori
manifest
fever
cough
short
breath
dyspnea
hypoxemia
chest
ct
examin
patient
show
predomin
ground
glass
opac
mix
consolid
mainli
peripher
combin
peripher
central
distribut
bilater
lower
lung
zone
mostli
involv
addit
attack
lead
collaps
immun
system
critic
ill
seriou
inhibit
immun
system
may
promot
replic
viru
spread
throughout
bodi
damag
function
multipl
organ
present
retrospect
studi
patient
found
statist
associ
age
mortal
none
interv
onset
hospit
mortal
percentag
men
rate
concomit
diseas
higher
patient
die
compar
survivor
differ
signific
perhap
due
small
sampl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
howev
admiss
baselin
leukocyt
count
neutrophil
percentag
neutrophil
count
death
group
significantli
higher
survivor
chang
et
al
report
initi
neutrophil
count
independ
risk
factor
death
patient
sar
singapor
scholar
also
conclud
neutropenia
predict
poor
prognosi
sar
leukocyt
count
sever
patient
significantli
higher
nonsever
patient
present
patient
found
neutrophil
count
higher
limit
normal
rang
dead
patient
initi
elev
neutrophil
count
independ
risk
factor
mortal
signific
elev
neutrophil
count
death
group
may
reflect
strong
inflammatori
respons
toward
viral
infect
possibl
combin
bacteri
infect
specif
mechan
need
studi
report
wang
et
al
patient
show
lymphocyt
count
continu
decreas
progress
unto
death
latest
research
show
sever
case
significantli
lower
lymphocyt
count
compar
nonsever
case
present
studi
also
determin
half
patient
lower
lymphocyt
count
lower
limit
normal
especi
die
found
lymphocyt
count
dead
group
significantli
lower
surviv
group
clear
whether
mechan
lymphocyt
declin
destruct
lymphoid
organ
viral
attack
lymphopenia
patient
sar
hormon
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
therapi
may
induc
stress
mechan
involv
hypothalamuspituitaryadren
axi
due
elev
cortisol
level
lymphocyt
subset
import
role
humor
cellular
immun
viral
infect
prognosi
variou
viral
diseas
close
link
cellular
immun
function
especi
lymphocyt
function
qin
et
al
found
number
helper
cell
suppressor
cell
regulatori
cell
decreas
patient
wang
et
al
report
cell
cell
b
cell
natur
killer
nk
cell
decreas
patient
significantli
lower
sever
case
mild
case
chen
et
al
show
cell
reduc
nearli
patient
sever
case
lower
level
moder
case
present
studi
patient
baselin
median
valu
count
lower
lower
limit
normal
rang
noteworthi
count
level
patient
die
significantli
lower
survivor
baselin
count
die
also
lower
compar
survivor
although
differ
two
group
statist
signific
studi
report
suppress
cellular
immun
patient
die
viral
pneumonia
one
studi
found
count
peripher
cell
substanti
lower
normal
man
die
infect
specul
decreas
number
lymphocyt
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
subset
may
caus
attack
immun
system
lam
et
al
report
natur
killer
cell
count
promis
predictor
intens
care
unit
admiss
patient
sar
present
studi
roc
analysi
determin
admiss
leukocyt
count
neutrophil
percentag
neutrophil
count
lymphocyt
percentag
lymphocyt
count
abl
predict
mortal
patient
term
cellular
immun
function
count
count
pao
fio
could
also
predict
mortal
clinician
pay
attent
paramet
care
patient
present
studi
humor
immun
function
patient
found
differ
igg
igm
iga
percentag
ige
iuml
signific
survivor
nonsurvivor
baselin
platelet
level
patient
die
lower
survivor
refer
viru
research
may
due
platelet
destruct
caus
viru
inhibit
product
platelet
bone
marrow
via
viral
infect
platelet
consumpt
caus
format
thrombu
injur
site
lung
hemoglobin
level
dead
patient
higher
surviv
patient
may
due
sever
lung
injuri
dead
patient
irrit
increas
hemoglobin
caus
hypoxemia
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
compar
admiss
week
hospit
blood
routin
examin
patient
group
surviv
show
neutrophil
lymphocyt
count
patient
return
normal
rang
worth
note
lymphocyt
count
level
surviv
patient
rise
lower
limit
normal
level
l
week
treatment
suggest
immun
function
patient
return
normal
addit
lymphocyt
subset
patient
also
return
normal
rang
posit
rate
rna
nasopharyng
swab
satisfactori
consid
hospit
discharg
patient
improv
symptom
obviou
absorpt
chest
ct
consecut
neg
nucleic
acid
test
import
howev
recommend
addit
lymphocyt
count
cellular
immun
function
test
conduct
ensur
diseas
effect
control
previou
studi
patient
sar
show
two
year
count
peripher
blood
lymphocyt
subset
compris
lymphocyt
nk
cell
remain
lower
healthi
control
patient
chang
lymphocyt
lymphocyt
subset
recoveri
need
studi
sever
limit
present
work
firstli
singlecent
retrospect
small
sampl
size
howev
best
knowledg
first
analys
dead
surviv
patient
routin
blood
immun
function
index
secondli
surviv
patient
select
timepoint
examin
blood
index
admiss
week
begin
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
hospit
treatment
may
accur
reflect
continu
dynam
chang
leukocyt
neutrophil
lymphocyt
lymphocyt
subset
final
number
patient
given
immun
function
test
later
die
rel
small
evalu
immun
function
cellular
immun
humor
immun
note
mortal
rate
studi
rel
high
one
studi
patient
report
death
rate
patient
among
patient
anoth
studi
mortal
rate
recent
largesampl
multicent
studi
show
patient
succumb
point
patient
present
studi
die
februari
higher
mortal
rate
like
result
heighten
sever
diseas
admit
patient
earli
stage
epidem
china
addit
treatment
area
temporari
structur
expedi
built
without
wellequip
intens
care
unit
medic
condit
insuffici
need
popul
patient
admiss
leukocyt
count
neutrophil
percentag
neutrophil
count
die
within
day
higher
survivor
lymphocyt
count
count
count
lower
neutrophil
count
independ
associ
mortal
leukocyt
neutrophil
lymphocyt
count
admiss
could
predict
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
mortal
due
